ArticleJournal of gynecologic oncology2022

SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis.

Yan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.